← Back to all signals
RESEARCH PAPER ANALYSIS

Effectiveness of the "Golden Hour" program in preventing sepsis in pediatric patients with acute lymphoblastic leukemia.

AI interpretation is pending for this paper.

Open original publication →
PMID42636482
JournalBoletin medico del Hospital Infantil de Mexico
Publication Date2026-01-01
Ingested2026-08-25 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

INTRODUCCIÓN: La iniciativa «Hora Dorada» se propone para reducir complicaciones graves en pacientes oncológicos pediátricos con neutropenia febril. Se refiere a la administración de antibiótico de amplio espectro en la primera hora de la atención en el servicio de urgencias. Los pacientes con leucemia linfoblástica aguda son de alto riesgo por la inmunosupresión prolongada. El objetivo fue determinar la administración de antibiótico dentro de los primeros 60 minutos como factor asociado a menor incidencia de sepsis en pacientes con leucemia linfoblástica aguda. MÉTODOS: Diseño de cohorte retrospectiva en expedientes de pacientes pediátricos con diagnóstico de leucemia linfoblástica aguda. Los grupos se integraron en función del tiempo de administración del antibiótico posterior al ingreso a triaje. En el grupo con administración oportuna (≤ 60 minutos) se estudiaron 44 pacientes y en el grupo con atención tardía (> 60 minutos), 11 pacientes. El diagnóstico de sepsis utilizó de referencia los criterios de Phoenix. El tiempo triaje-administración de antibiótico se midió en minutos. El análisis estadístico incluyó regresión logística simple y cálculo de probabilidad de ocurrencia del evento. RESULTADOS: El 54.5% del grupo con atención tardía desarrolló sepsis, en el grupo con atención oportuna la incidencia fue del 22.7% (p = 0.038). El modelo de regresión logística reportó significancia (p = 0.004). La probabilidad de desarrollar sepsis fue del 49.1% a los 80 minutos, el 35.5% a los 60 minutos y el 56% a los 90 minutos. CONCLUSIONES: La administración de antibiótico dentro de los primeros 60 minutos se asoció con menor incidencia de sepsis en pacientes con leucemia linfoblástica aguda. BACKGROUND: The “Golden Hour” initiative is intended to reduce serious complications in pediatric oncology patients with febrile neutropenia, and it refers to the administration of broad-spectrum antibiotics within the first hour of care in the emergency department. Patients with acute lymphoblastic leukemia are at high risk due to prolonged immunosuppression. The objective was to determine the administration of antibiotics within the first 60 minutes as a factor associated with a lower incidence of sepsis in patients with acute lymphoblastic leukemia. METHODS: Retrospective cohort design in the records of pediatric patients diagnosed with acute lymphoblastic leukemia, with groups organized based on the time of antibiotic administration after triage admission. In the timely administration group (≤ 60 minutes), 44 patients were studied, and in the delayed care group (> 60 minutes), 11 patients. The diagnosis of sepsis used the Phoenix criteria as a reference. The time between triage and antibiotic administration was measured in minutes. The statistical analysis included simple logistic regression and calculation of the probability of the event occurring. RESULTS: Fifty-four percent of the late-care group developed sepsis, while in the timely-care group the incidence was 22.7% (p = 0.038). The logistic regression model reported significance (p = 0.004). The probability of developing sepsis was 49.1% at 80 minutes, 35.5% at 60 minutes, and 56% at 90 minutes. CONCLUSIONS: Antibiotic administration within the first 60 minutes was associated with a lower incidence of sepsis in patients with acute lymphoblastic leukemia.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Biomarker-Negative and MIBG-Negative Neuroblastoma Presenting as an Indeterminate Retroperitoneal Mass in a Young Child. Pediatrics international : official journal of the Japan Pediatric Society 29.85 2 Hypophosphatemic rickets in children: current knowledge and a proposal for a diagnostic algorithm. Endokrynologia Polska 58.0 3 Clinical validation of the nursing diagnosis of inadequate nutritional intake in children with cancer. International journal of nursing knowledge 67.6 4 Exploratory Analysis of the Inhibitory Effects of Propranolol on NLRP3 and Pyrin Inflammasomes. ACR open rheumatology 56.76 5 First-In-Human Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of Tilpisertib Fosmecarbil (GS-5290), an Oral Prodrug of a Tumor Progression Locus 2 Inhibitor in Healthy Participants. Journal of clinical pharmacology 84.72 6 Dyadic Latent Profiles of Sexual and Reproductive Distress in Young Adult Cancer Survivors and Their Partners: A Cross-Sectional Analysis. Psycho-oncology 61.0 7 Disproportionality analysis of drug-induced myocarditis: Insights from the Food and Drug Administration Adverse Event Reporting System database. The Journal of international medical research 63.68 8 Innovative Insights into Osteosarcoma: Unraveling the Role of LncRNAs, miRNAs, and CircRNAs in Tumorigenesis and Therapeutic Resistance. Current gene therapy 63.84 9 Targeting Metal-Dependent Cell Death in Cancer: From Molecular Circuitry to Biomarker-Guided Precision Combination Therapy. Current cancer drug targets 70.99 10 Long-term outcomes of non-operative compared to operative management of acute uncomplicated appendicitis - a systematic review and meta-analysis. American journal of surgery 72.5 11 What have I missed again: A qualitative study exploring parents of children with cancer's experiences of fear of missing out. Journal of health psychology 54.0 12 Radiographic overestimation of inferior vena cava involvement in pediatric neuroblastoma: a case report. Journal of surgical case reports 55.5 13 Global Burden and Temporal Trends of Brain and Central Nervous System Tumors in Children and Adolescents: A Systematic Analysis for the Global Burden of Disease Study 2021. Cancer innovation 56.0 14 Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report. The American journal of case reports 53.92 15 Modern management and multidisciplinary care of bladder prostate rhabdomyosarcoma. Current opinion in pediatrics 62.8 16 Improving Dietary Data Quality in Nutrition Studies: Development and Validation of an Explainable, Reproducible, Open Machine Learning-Assisted Framework for Outlier Detection in 24-Hour Recalls. American journal of epidemiology 61.5 17 Genetic Markers of Early Skeletal Muscle Loss in Adolescent and Young Adult Cancer Patients Treated with Anthracyclines. Journal of adolescent and young adult oncology 65.5 18 Seen, Heard, and Still Missing: Understanding Clinical Trial Nonparticipation Among Women of Color. Journal of adolescent and young adult oncology 74.5 19 Correction to "Health-Related Quality of Life in Chinese Children and Adolescents With Cancer: A Systematic Review and Meta-Analysis". International journal of cancer 63.0 20 Evolution of robotic-assisted resection of pediatric neuroblastic tumors: a retrospective analysis. Updates in surgery 61.5 21 Late cardiac effects of anthracycline-based therapy in childhood cancer survivors: a CMR study of cardiac strain and function. Clinical research in cardiology : official journal of the German Cardiac Society 68.34 22 Biological reconstruction in the growing child after tumour resection: long-term outcomes of vascularized fibular epiphyseal transfer. International orthopaedics 57.2 23 Neuroimaging findings of the hypothalamus and pituitary gland in children with growth hormone deficiency: a 25-year single-center retrospective study. Hormones (Athens, Greece) 67.0 24 Ovarian Lymphoma and Bone Metastasis Presenting With Paraparesis in an Adolescent: A Case Report. The American journal of case reports 51.9 25 Evaluating the impact of virtual oncology financial and legal navigation on cancer-related financial toxicity. JNCI cancer spectrum 63.12 26 Pharmacogenetic variants in the molecular characterization initiative: a report from the children's oncology group. Journal of the National Cancer Institute 65.4 27 Impact of Satisfactory Family Coping on the Mental Health of Parents Whose Children Died of Cancer. Journal of pain and symptom management 59.5 28 Surgical approach to solid breast masses in girls. Journal of pediatric and adolescent gynecology 58.4 29 Pediatric and Adolescent Gynecological Tumors and Associated Predisposition Syndromes. Journal of pediatric and adolescent gynecology 56.0 30 Facial nerve schwannoma of the accessory parotid gland region in a child managed through a transoral approach. BMJ case reports 56.0 31 Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study. The Lancet. Oncology 85.2 32 "This Is Loneliness, Helplessness, Desolation…": Exploring the Emotions and Emotion Regulation Experiences of Mothers of Children Diagnosed With Acute Lymphoblastic Leukemia. Cancer nursing 58.5
PATIENT-FRIENDLY SUMMARY

Effectiveness of the "Golden Hour" program in preventing sepsis in pediatric patients with acute lymphoblastic leukemia.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic